Well we don't know whether the patient with 'zero tumour burden' is that yellow line on the graph. I stated that the person is likely the one who achieved a CR. This graph just tells us about antibodies and we know there are only 7 lines. We know that 3 people are still living and are on the trial, however only 1 of the lines runs all the way to the end at 42 weeks. Given that the graph is aiming to demonstrate that a there is a correlation between dosage and antibody production between each of the arms, I think it does a good job at depicting that.
Remember our objectives in a phase 1 trial.
You're missing that every patient in the trial was in 1 of the monotherapy treatment arms, all with varying levels of IMU-201 (PD1-Vaxx), with no other treatment. So the only conclusion would be that the patient on the trial has had a health benefit from PD1-Vaxx and their immune system has been able to kill off the tumour with no reoccurrence 18months later.
Remember to be eligible for the trial, all patients needed to:
1. Histologically confirmed non-small-cell lung cancer (NSCLC) tumor stage IIIb or IV (3 major types of NSCLC are acceptable including squamous, adenocarcinoma, and large cell carcinoma);
2. Progressed on an approved PD-1 inhibitor or an approved PD-L1 inhibitor. Patients previously treated with a combination of an approved PD-1 or an approved anti-PD-L1 inhibitor and chemotherapy may be included with agreement of Imugene Limited
Sourced from A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer - Full Text View - ClinicalTrials.gov
- Forums
- ASX - By Stock
- Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC
Well we don't know whether the patient with 'zero tumour burden'...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $373.3M |
Open | High | Low | Value | Volume |
5.2¢ | 5.2¢ | 5.0¢ | $669.7K | 13.07M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1074997 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 1209633 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 1074997 | 0.051 |
42 | 3460275 | 0.050 |
33 | 3784850 | 0.049 |
19 | 1296168 | 0.048 |
11 | 961292 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 1209633 | 6 |
0.053 | 2764169 | 16 |
0.054 | 1794757 | 7 |
0.055 | 1524326 | 12 |
0.056 | 633333 | 4 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |